LIG1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.567200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.898400E-01
Normal-vs-Stage2
5.598400E-01
Normal-vs-Stage3
2.950800E-01
Normal-vs-Stage4
3.683400E-01
Stage1-vs-Stage2
6.335200E-01
Stage1-vs-Stage3
5.060000E-01
Stage1-vs-Stage4
9.407400E-01
Stage2-vs-Stage3
3.351000E-01
Stage2-vs-Stage4
6.582800E-01
Stage3-vs-Stage4
6.237200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.544200E-01
Normal-vs-AfricanAmerican
5.204400E-01
Normal-vs-Asian
6.706200E-01
Caucasian-vs-AfricanAmerican
8.528600E-01
Caucasian-vs-Asian
3.971400E-01
AfricanAmerican-vs-Asian
7.600000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.277400E-01
Normal-vs-Female
5.951200E-01
Male-vs-Female
2.591200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.402200E-01
Normal-vs-Age(41-60Yrs)
5.836200E-01
Normal-vs-Age(61-80Yrs)
5.504800E-01
Normal-vs-Age(81-100Yrs)
5.563400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.098800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.679400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.229600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.311000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.143800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.788400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.013200E-01
Normal-vs-Daily Drinker
3.641600E-01
Normal-vs-Weekly Drinker
5.904800E-01
Normal-vs-Occasional Drinker
6.290400E-01
Normal-vs-Social Drinker
4.981400E-01
Non Drinker-vs-Daily Drinker
5.895800E-01
Non Drinker-vs-Weekly Drinker
8.832600E-01
Non Drinker-vs-Occasional Drinker
6.580600E-01
Non Drinker-vs-Social Drinker
5.768200E-01
Daily Drinker-vs-Weekly Drinker
7.185200E-01
Daily Drinker-vs-Occasional Drinker
9.182800E-01
Daily Drinker-vs-Social Drinker
2.707000E-01
Weekly Drinker-vs-Occasional Drinker
7.645200E-01
Weekly Drinker-vs-Social Drinker
4.702400E-01
Occasional Drinker-vs-Social Drinker
2.514400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.329400E-01
Normal-vs-Grade 2
9.332600E-01
Normal-vs-Grade 3
5.114400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.414400E-01
Grade 1-vs-Grade 3
1.729010E-01
Grade 1-vs-Grade 4
8.329400E-01
Grade 2-vs-Grade 3
3.183800E-02
Grade 2-vs-Grade 4
9.332600E-01
Grade 3-vs-Grade 4
5.114400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.800000E-01
Normal-vs-NonDiabetic
6.047200E-01
Diabetic-vs-NonDiabetic
7.421700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.770200E-01
Normal-vs-NoPancreatitis
5.554000E-01
Pancreatitis-vs-NoPancreatitis
3.766200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.213200E-01
Normal-vs-N1
5.375200E-01
N0-vs-N1
2.244600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.918800E-01
Normal-vs-TP53-NonMutant
5.915200E-01
TP53-Mutant-vs-TP53-NonMutant
2.116400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
